Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis C Szoka

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|July 20, 2022
A hitchhiker's guide to mucosal and systemic immunityFrancis C Szoka
Journal of Drug Targeting|September 8, 2016
Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratiosMatthew Tiffany, Francis C Szoka
Molecular Pharmaceutics|May 17, 2018
Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug DeliveryAaron Dolor, Francis C Szoka
Accounts of Chemical Research|March 21, 2012
Nucleic acid delivery: the missing pieces of the puzzle?Juliane Nguyen, Francis C Szoka
Pharmaceutical Research|January 26, 2007
Lipid-based nanoparticles for nucleic acid deliveryWeijun Li, Francis C Szoka
Accounts of Chemical Research|May 21, 2003
Chemical approaches to triggerable lipid vesicles for drug and gene deliveryXin Guo, Francis C Szoka
Journal of the American Chemical Society|October 28, 2008
Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane propertiesZhaohua Huang, Francis C Szoka
CSH Protocols|April 10, 2012
Bioresponsive targeted charge neutral lipid vesicles for systemic gene deliveryWeijun Li, Francis C Szoka
Chemical Communications (Cambridge, England)|November 3, 2011
Zwitterionic sulfobetaine lipids that form vesicles with salt-dependent thermotropic propertiesEmily K Perttu, Francis C Szoka
Advanced Drug Delivery Reviews|February 24, 2015
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapyJonathan T Sockolosky, Francis C Szoka
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|July 20, 2022
A hitchhiker's guide to mucosal and systemic immunityFrancis C Szoka
Journal of Drug Targeting|September 8, 2016
Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratiosMatthew Tiffany, Francis C Szoka
Molecular Pharmaceutics|May 17, 2018
Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug DeliveryAaron Dolor, Francis C Szoka
Accounts of Chemical Research|March 21, 2012
Nucleic acid delivery: the missing pieces of the puzzle?Juliane Nguyen, Francis C Szoka
Pharmaceutical Research|January 26, 2007
Lipid-based nanoparticles for nucleic acid deliveryWeijun Li, Francis C Szoka
Accounts of Chemical Research|May 21, 2003
Chemical approaches to triggerable lipid vesicles for drug and gene deliveryXin Guo, Francis C Szoka
Journal of the American Chemical Society|October 28, 2008
Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane propertiesZhaohua Huang, Francis C Szoka
CSH Protocols|April 10, 2012
Bioresponsive targeted charge neutral lipid vesicles for systemic gene deliveryWeijun Li, Francis C Szoka
Chemical Communications (Cambridge, England)|November 3, 2011
Zwitterionic sulfobetaine lipids that form vesicles with salt-dependent thermotropic propertiesEmily K Perttu, Francis C Szoka
Advanced Drug Delivery Reviews|February 24, 2015
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapyJonathan T Sockolosky, Francis C Szoka
Pageof 10